EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Radiotherapy with or without concurrent cetuximab in HPV-positive oropharyngeal squamous cell carcinoma – A pooled analysis from two ARTSCAN trials

Gabriel Adrian, Per Nilsson, Signe Friesland, Hedda Haugen Cange, Karin Söderkvist, Johan Reizenstein, Björn Zackrisson, Maria Gebre-Medhin

Clinical and Translational Radiation Oncology · 2026-07 · 59 · 101202

DOI: 10.1016/j.ctro.2026.101202 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Translational Radiation Oncology, 2026-07. Verfasst von Gabriel Adrian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Svenska Sällskapet för Medicinsk Forskning, Fru Berta Kamprads Stiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CetuximabEpidermal Growth Factor Receptor inhibitorHPV-associated squamous cell carcinomaOropharyngeal squamous cell carcinomaRadiotherapy

Autor:innen und Institutionen

  • Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
  • Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden.
  • Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Oncology, Sahlgrenska University Hospital, Göteborg, Sweden.
  • Department of Diagnostics and Interventions, Oncology, Umeå University, Umeå, Sweden.
  • Department of Oncology, Örebro University Hospital, Örebro, Sweden.

Förderung

  • Svenska Sällskapet för Medicinsk Forskning
  • Fru Berta Kamprads Stiftelse

Zitieren

APA

Adrian, G., Nilsson, P., Friesland, S., Cange, H. H., Söderkvist, K., Reizenstein, J., Zackrisson, B., & Gebre-Medhin, M. (2026). Radiotherapy with or without concurrent cetuximab in HPV-positive oropharyngeal squamous cell carcinoma – A pooled analysis from two ARTSCAN trials. Clinical and Translational Radiation Oncology, 59, 101202. https://doi.org/10.1016/j.ctro.2026.101202

Vancouver

Adrian G, Nilsson P, Friesland S, Cange HH, Söderkvist K, Reizenstein J, et al. Radiotherapy with or without concurrent cetuximab in HPV-positive oropharyngeal squamous cell carcinoma – A pooled analysis from two ARTSCAN trials. Clinical and Translational Radiation Oncology. 2026;59:101202. doi:10.1016/j.ctro.2026.101202

BibTeX
@article{Adrian2026,
  author = {Adrian, Gabriel and Nilsson, Per and Friesland, Signe and Cange, Hedda Haugen and Söderkvist, Karin and Reizenstein, Johan and Zackrisson, Björn and Gebre-Medhin, Maria},
  title = {Radiotherapy with or without concurrent cetuximab in HPV-positive oropharyngeal squamous cell carcinoma – A pooled analysis from two ARTSCAN trials},
  journal = {Clinical and Translational Radiation Oncology},
  year = {2026},
  volume = {59},
  pages = {101202},
  doi = {10.1016/j.ctro.2026.101202}
}
Kostenlos starten →